Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Ameristar Casinos

(ASCA)

downgraded at Goldman from Neutral to Sell. Stock is up 44% year-to-date and the company is facing increased competition. $20 price target.

Cracker Barrel

(CBRL) - Get Report

downgraded at Argus from Buy to Hold. Company is seeing lower sales.

Cracker Barrel

downgraded at BofA/Merrill from Buy to Underperform. Company is facing growth headwinds. $44 price target.

Dendreon

(DNDN)

rated new Buy at Goldman Sachs. $50 price target. Provenge is a potential blockbuster drug.

Devry

(DV)

upgraded at BofA/Merrill to Buy. Gainful employment regulation was softened. $68 price target.

Education Management

(EDMC)

upgraded at BofA/Merrill from Underperform to Neutral, Bank of America/Merrill Lynch said. $24 price target. DOE has lessened its regulations on the for-profit group.

Express

(EXPR) - Get Report

rated new Buy at Brean Murray. $26 price target. Company can continue to expand margins, despite rising input costs.

General Mills

(GIS) - Get Report

downgraded at UBS from Buy to Neutral. Valuation call, based on a $41 price target.

Heinz

(HNZ)

upgraded at UBS from Neutral to Buy. $62 price target. Company can deliver above-consensus growth over the next several quarters.

Pharmasset

(VRUS)

rated new Buy at Brean Murray. $174 price target. Company is a market leader in what should become a top hepatitis C therapy.

End of report.

This article was written by a staff member of TheStreet.